W ith the advent of better discovery tools, such as cell sorting and high-resolution microscopic imaging, it has become possible to identify and subsequently purify various populations of stem cells (SCs) from adult tissues, which possess the ability to self-renewal. However, SCs are heterogenous and follow a developmental hierarchy. Moreover, evidence has accumulated that in several organs, including bone marrow (BM), it may reside a dormant population of rare, primitive, and quiescent SCs among more numerous tissue-committed SCs (TCSCs). [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] It has been demonstrated that some of these SCs possess transgerm layer differentiation potential.
It is widely accepted that SCs have a distinct morphology (ie, small size and with a lymphocyte-like appearance), express a distinct panel of surface markers (ie, CD133 , and display differences in activity of certain enzymes (eg, aldehyde dehydrogenase [ALDH] ). All of these traits are helpful in SC identification and in purification strategies. [21] [22] [23] [24] [25] An intriguing question has also been raised: Do already lineage-committed TCSCs residing in adult tissues show plasticity and transdedifferentiate into cells from other lineages? [26] [27] [28] [29] This concept is based on the hypothesis that SCs already committed to a given tissue, for example, hematopoietic SCs (HSCs), can transdedifferentiate and become SCs for different types of tissues-for example, cardiac or liver SCs. However, this hypothesis has been challenged because it has been hard to reproduce some of the initially published (and perhaps optimistic) reports showing robust transdedifferentiation of one type of TCSC into SCs for other tissues. 30, 31 Instead, several other alternative explanations have been proposed to explain the involvement of SCs in tissue repair, including (1) cell fusion, 32 (2) the involvement of SC paracrine effects by soluble factors and SC-derived extracellular microvesicles, 33, 34 or (3) the presence of rare pluripotent or multipotent SCs in adult tissues that are developmental precursors for various types of TCSCs. 35 Examples of such published reports of SCs with broader pan-germ-layer differentiation potential include (1) mesenchymal SCs (MSCs), 14, 36, 37 (2) multipotent adult progenitor cells, 6, 38 (3) marrow-isolated adult multilineage inducible cells, 4 (4) multipotent adult SCs, 3 (5) elutriation-derived (Fr25/ Lin -) SCs (ELH SCs), [39] [40] [41] (6) spore-like SCs, 19 (7) pluripotent Sca-1 + CD45 -c-kit -cells, 20 (8) multilineage-differentiating, stress-enduring SCs, 13, 15, 42 and (9) very small embryonic-like SCs (VSELs), described by our group. 1, [43] [44] [45] All of these SC types were identified by using different direct or indirect isolation protocols and identification techniques. The similarity in expression of certain early-development genes in these cells suggests that they are related to each other, that they may represent similar, overlapping populations of primitive SCs that reside in adult tissues, and that they are endowed with broader cross-germ-layer differentiation potential.
In this review, we will focus on VSELs, as these cells (≈4-5 μm in diameter as measured in murine BM and ≈5-6 μm in human BM or umbilical cord blood [UCB]) have been highly purified and well characterized at the molecular level. [46] [47] [48] We propose that VSELs represent the most primitive population of quiescent SCs residing in adult tissues and resemble some of their properties of other primitive SCs described by other investigators (eg, ELH SCs). The small size of these cells and the paucity of mitochondria are signs of their quiescence and low metabolic activity. 49 These very rare cells are isolated from adult tissues (eg, BM, UCB, and mobilized peripheral blood [mPB] ) by multiparameter cell sorting (Figure 1 ), and several groups that carefully followed the original protocol for their isolation (published by us in Current Protocols of Cytometry 50 or contacted us for help) successfully identified these small cells in postnatal tissues. [51] [52] [53] [54] BM-purified VSELs have been demonstrated by other investigators to be precursors of HSCs, 55, 56 MSCs, 57, 58 endothelial SCs, 59 ,60 lung alveolar epithelial cells, 61, 62 and cardiomyocytes. 63, 64 At the same time, VSELs isolated from gonads have been proposed to be precursors of male and female gametes. 18, [65] [66] [67] What is of particular interest, we have recently developed an efficient protocol to expand these highly quiescent cells isolated from human and murine hematopoietic tissues in chemically defined media, without support of third-party feeder-layer cells or transduction by vectors encoding pluripotency-promoting factors. This newest development opens up new and exciting possibilities for VSEL application in regenerative medicine.
Hierarchy of the SC Compartment in Embryonic and Postnatal Tissues: Do We Have a Definitive Model?
The most accepted, but unfortunately oversimplified, view of the BM SC compartment is based on the assumption that it consists of HSCs, MSCs, and endothelial progenitor cells (EPCs). However, this old and dogmatic view has been challenged by several reports that suggest the presence of other more primitive SCs in BM tissue. [2] [3] [4] 6, 13, 14, 19, 20, 38, 42, 68 SCs possess the unique property of symmetrical self-renewal or asymmetrical division, and evidence indicates that they are not all equal from a hierarchical point of view. Some of them may be endowed with broader differentiation potential across germ layers. [69] [70] [71] [72] [73] [74] [75] Thus, the hierarchy of the SC compartment needs to be revisited, as many of the early-development SCs may be left unaccounted for in a simplified hierarchy.
From a developmental point of view, the most primitive SCs are the fertilized oocyte (zygote) and the first blastomeres in the morula, as these cells are able to give rise to both embryo and placenta. Such SCs are called totipotent. By contrast, embryonic SCs (ESCs) isolated from the inner cell mass (ICM) of the blastocyst differentiate into embryonic tissues only, losing the ability to form the placenta and are therefore called pluripotent SCs (PSCs). After implantation of the blastocyst into the uterus, ICM-derived PSCs of the blastocyst form the epiblast, and epiblast SCs (EpiSCs) subsequently give rise to all 3 germ layers (meso-, ecto-, and endoderm), including primordial germ cells (PGCs). Pluripotent EpiSCs gradually loss their pluripotency by giving rise to multipotent SCs, which are specific for one of the germ layers, and finally monopotent TCSCs, for example, SCs for epidermis, intestinal epithelium, liver, skeletal muscle, or lymphohematopoiesis. TCSCs in adult organisms reside in SC niches (eg, in the basal layer of epidermis and hair budge [ ). In heart, SCs are thought to be located in the atrial appendages. [76] [77] [78] [79] [80] [81] Although considering the hierarchy of the SC compartment and their developmental specification, beginning with PSCs and ending with TCSCs, an important question emerges: Is the differentiation process of PSCs or multipotent PSCs during embryogenesis complete, or perhaps do some of these early-development SCs survive beyond embryogenesis into adulthood and remain as a hibernated or a quiescent backup population of TCSCs? This possibility is supported by the presence in adult BM, UCB, and mPB of VSELs and other rare SC populations that express embryonic, epiblast, and PGC markers that overlap with VSELs. Examples of such cells detected in adult tissues are listed in the Table. One of the intriguing puzzles in mammalian development is the fact that PGCs are the first population of SCs specified before gastrulation in the proximal epiblast-a precursor of the entire embryo proper. 82 (eg, EpiSCs) may be deposited in adult tissues as a population of dormant SCs that are endowed with broad, cross-germlayer differentiation potential. [69] [70] [71] [72] [73] [74] [75] 84, 85 What is also an intriguing hypothesis is that the developmental migration of PGCs from the epiblast over the extraembryonic tissues and back to the gonadal ridges may be related to the developmental origin of HSCs and EPCs. First, at the Figure 1 . Identification and isolation of very small embryonic-like stem cells (VSELs) and hematopoietic SCs (HSCs) from human umbilical cord blood by using fluorescence-activated cell sorter (FACS) sorter. To develop a more efficient and less time consuming method for purifying VSELs from UCB, we developed a 3-step isolation strategy based on (1) removing erythrocytes by hypotonic lysis, (2) time when PGCs migrate through the extraembryonic tissues, the first hemangioblasts, which are precursors of primitive HSCs and EPCs, emerge at the bottom of the yolk sac. 86 Later on, when the PGCs migrate across the embryo proper to the genital ridges and pass through the aorta-gonado-mesonephros region, the first definitive HSCs emerge in the aortic endothelium. 87 This potential link between PGC migrationthe emergence first of hemangioblasts and later on definitive HSCs-suggests that the developmental origin of VSELs is from migrating PGCs. 2, 47, 88, 89 In support of this concept, both PGCs and VSELs are reportedly able to give rise to HSCs and EPCs. 55, 56, [90] [91] [92] Moreover, PGC-derived precursors of gametes, VSELs, and HSCs express several functional sex hormone (SexH) receptors and the erythropoietin receptor. Moreover, VSELs highly express certain hemangioblast markers (eg, Flk1) and, as reported in an elegant study, they can be specified into endothelial cells in vitro and in vivo. 47, 59, 88, 89, 93 This concept of the origin of definitive HSCs from migrating PGCs has been recently demonstrated in elegant work by the Scaldaferri et al 94 and discussed in an inspiring review by Virant-Klun. 95 Nevertheless, as always with new scientific ideas, more experimental evidence is needed to support this novel and intriguing concept.
Evidence for the Presence of Very Small SCs in Adult Tissues: A Roadmap for Discovery of Very Small Embryonic-Like SCs
SCs are characterized by a high nuclear/cytoplasmic ratio, and one may make the assumption that those that are more quiescent and dormant (eg, VSELs) compared with those that are actively proliferating (eg, HSCs or intestinal epithelium SCs) are much smaller and contain only sparse, round mitochondria as signs of low metabolic activity. 1, 96, 97 In support of this claim, several types of small SCs were initially described in hematopoietic tissues and later confirmed to be present in other organs as well. The exact size of the small SCs may depend on the method of their measurement (microscopic template grids or size beads) and may also be affected by procedures such as fixation or mounting on slides. In general, we consider small cells to be up to 5 μm in diameter for mice and slightly larger in humans. We will briefly discuss these cells, keeping in mind the tempting speculations that these SCs could be precursors for multipotent adult progenitor cell, marrow-isolated adult multilineage inducible cells, multipotent adult SCs, MSCs, or multilineage-differentiating, stress-enduring SCs. It is likely that these particular SCs, which seem to be somewhat larger, from the beginning have been contaminated by populations of small SCs attached to them or internalized by a process of emperipolesis. 98 Below, we will briefly summarize examples of small SCs that have been isolated from murine, rat, and human tissues. These cells were identified primarily as candidates for quiescent HSCs. However, with time it became obvious that some of them are also endowed with broader differentiation potential across germ layers.
Small SCs With Primary Hematopoietic Potential

Lin
-/ALDH high Long-Term Repopulating HSCs The population of small, long-term repopulating HSCs, which were isolated by using elutriation followed by fluorescenceactivated cell sorter and selection for high activity of ALDH (ALDH high ) and not hematopoietic lineage markers (which these cells lack), was described by Jones et al 25 and Sharkis et al. 99 Although the exact size of these cells was not published in the original publication, a recent article from this group described these SCs as <5 µm. 61 These interesting cells, however, were not analyzed for the expression of pluripotent or multipotent SC markers. However, recent evidence suggests their broader nonhematopoietic differentiation potential ( 
BM Mononuclear Cell-Derived Progenitor-Like Cells
Small cells (≈4-5 µm in diameter) in BM were identified by using the electron microscopy by Matsuoka et al. 100 This population of small cells exhibited certain morphological features 
) SCs
As mentioned above, these interesting SCs were initially described as Lin -/ALDH high long-term repopulating HSCs. 25, 41, 99, 103 More careful analysis of these cells and modification of their isolation strategy by elutriation (E, Fr25), combined with their lineage negativity (L) and transplantation into lethally irradiated mice and recovery by fluorescence-activated cell sorter after short-term homing (H), demonstrated that they contribute to multiple epithelial tissues. Recent experiments from the Krause group 62 demonstrated that they are distinct from classical HSCs and may repopulate lung alveolar type II pneumocytes, producing surfactant after transplantation into surfactant-deficient mice. These particular SCs have been recently proposed to overlap with VSELs. 61 Similar small Lin -SCs isolated by elutriation (Fr25) from murine BM were shown to contribute to regeneration of retinal epithelium and to differentiate into insulinproducing cells in mice. 
Spore-Like SCs
The presence of small SCs (≈5 µm) in adult tissues known as spore-like SCs was demonstrated by Vacanti et al. 19 Unfortunately, the isolation strategy and the exact markers for these cells were not described in the original publication.
VSEL-Like SCs in Murine and Human Gonads
Very small SCs with pluripotent characteristics were described in the human and murine ovarian surface epithelium and identified in murine and human testes independently by the Virant-Klun and Bhartiya groups. 18, [65] [66] [67] 106 These small cells express embryonic markers such as SSEA, Oct-4, Sall4, Nanog, and Sox-2 and are able to form embryoid body-like structures in vitro. It was proposed that these cells are the precursors of gametes. 108 isolated a population of very small SCs residing in human BM that were able to migrate through the 3-μm pores.
VSEL-Like SCs in Rat BM
All of these small SCs listed above, which were isolated from adult tissues, most likely represent overlapping cell populations. Although many of them were not well characterized at the molecular level, we envision that they are closely related to VSELs in the developmental hierarchy. This concept will be presented in more detail below.
Discovery of VSELs and Their Challenge to Understanding the Adult SC Compartment
Evidence has accumulated for a very likely scenario in which some primitive epiblast/PGC-derived SCs escape specification into TCSCs and thus retain their pluripotent character and survive as VSELs into adulthood, forming a reserve pool of precursors for TCSCs. Thus, VSELs could play an important role in tissue rejuvenation and regeneration.
VSELs were initially purified by using fluorescenceactivated cell sorter-based multiparameter sorting of murine BM and several adult murine organs (eg, brain, liver, skeletal muscle, heart, gonads, and kidney). 45, 49, 50 Murine BM-derived VSELs (1) are very rare (≈0.01% of nucleated BM cells), (2) are small in size (≈3-5 μm), (3) express several PSC markers, including Oct4, Nanog, Rex-1, and SSEA-1, (4) contain sparse, round mitochondria, and (5) have large nuclei filled with unorganized chromatin (euchromatin). Importantly, to exclude expression of Oct-4 pseudogenes in these cells, we confirmed the true expression of Oct4 by demonstrating transcriptionally active hypomethylated DNA associated with acetylated histone chromatin in the Oct4 promoter.
46,47 The Oct-4 amplicon was also sequenced for accuracy.
Moreover, a corresponding population of small (≈4-7 μm) CD133 + Lin -CD45 -SCs that display embryonic-like cell morphology have been purified from UCB and mPB. 51, 57, 109, 110 Human VSELs, like murine VSELs, have large nuclei that contain unorganized euchromatin and a relatively small rim of cytoplasm with sparse, round mitochondria. These cells also express Oct4 and Nanog in their nuclei and display the SSEA-4 antigen on their surface. 109 Evidence indicates that VSELs are a population of migratory cells, and their number increases both in mice and in humans in PB during stress situations related to tissue or organ injuries (eg, heart infarct, stroke, skin burns, or acute colitis). 64, [111] [112] [113] [114] These cells, which are mobilized into PB where they then circulate, may play a physiologically important surveillance role in repairing minor tissue damage. The elevated number of VSELs observed in UCB may be explained as a physiological mechanism in which these cells are mobilized in newborns, which, because of hypoxia and delivery stress, experience numerous minor tissue injuries. Thus, the mobilization of VSELs into UCB is an inborn protective mechanism, which can be considered as the original physiological SC therapy, that everybody experiences in life after delivery. The number of VSELs circulating in PB also increases after administration of certain drugs that are used on a routine basis in the clinic to mobilize HSCs into PB (eg, G-CSF [granulocyte-colony stimulating factor] or AMD3100 [Plerixafor, Mozobil]). 51, 115 Thus, VSELs could be harvested for potential clinical applications, like HSCs from mPB, by using similar protocols for leucophoresis. The problem of low recovery of these cells from BM, UCB, and mPB is ameliorated by a recently established ex vivo expansion protocol for these cells (see below).
As recently reported, the number of VSELs in murine BM increases in vivo in response to regular physical activity and prolonged caloric restriction. 116, 117 On the contrary, highly quiescent VSELs in murine BM may enter the cell cycle, as confirmed by bromodeoxyuridine accumulation in these cells after administration of SexHs (such as follicle-stimulating factor or luteinizing hormone) or erythropoietin. 88, 89 The responsiveness of VSELs to SexHs supports a developmental relationship of these cells to PGC progeny and has been recently used in our ex vivo-expansion protocol for these cells (see below).
Molecular Characteristics of VSELs: Evidence for Their Pluripotency or Multipotency
According to their definition, PSCs should, at the molecular level (1) express acknowledged markers of pluripotency, (2) have bivalent domains at promoters for homeodomain-containing transcription factors (TFs), and (3) have 2 active X chromosomes in female PSCs. VSELs have been carefully characterized according to these criteria by using several complementary techniques, including gene expression studies at the mRNA level, miRNA analysis, the creation of cDNA libraries from highly purified cells, DNA methylation studies, the analysis of histone methylation and acetylation, and direct immunostaining. 47, 48, 118 All of these studies revealed that VSELs express several markers characteristic of PSCs. However, at the same time, our single-cell-sorted library results indicate that, despite similar morphology and expression of similar surface markers, these cells residing in adult BM are somewhat heterogeneous in the expression of certain lineagespecific genes. 48 In support of their pluripotency, VSELs express several genes characteristic of PSCs (eg, Oct-4, SSEA, Nanog, Sox-2, Klf4, and Rex-1). Moreover, adult murine BMderived VSELs express genes characteristic of EpiSCs (Gbx2, Fgf5, and Nodal) and of blastocyst ICM-derived ESCs (Rex1, also known as Zfp42). 47 However, it was found that Gbx2, Fgf5, and Nodal transcripts are expressed at higher levels than Rex1 in VSELs, in contrast to the expression pattern in the established murine ESC cell-line ESC-D3. 47 This finding strongly suggests that VSELs are more differentiated than ICM-derived ESCs and share several markers with the more differentiated EpiSCs. 46, 47 Molecular analysis also revealed that VSELs are developmentally related to epiblast-derived PGCs, as they express transcripts for Stella, Prdm14, Fragilis, Blimp1, Nanos3, and Dnd1. 47 The protein expression of PGC markers such as Stella, Blimp1, and Mvh in purified VSELs was subsequently confirmed by immunostaining. More importantly, chromatin immunoprecipitation results revealed that the Stella promoter in VSELs displays transcriptionally active histone modifications (acetylated histone 3 and trimethylated lysine 4 of histone 3) and was less enriched for transcriptionally repressive histone markers (dimethylated lysine 9 of histone 3 and trimethylated lysine 27 of histone 3). 47 At the same time, VSELs also highly express transcripts for Dppa2, Dppa4, and Mvh, which are characteristic of late migratory PGCs; however, they do not express the Sycp3, Dazl, and LINE1 genes, which are markers of postmigratory PGCs. 47 Finally, the partial DNA demethylation of repetitive DNA sequences (LINE1 and IAP) and promoters of Mvh and Sycp3 further supports a close relationship between VSELs and late-migratory PGCs. 47 As mentioned above, a potential relationship between VSELs and PGCs is also somewhat supported by the expression of several pituitary and gonadal SexH receptors by these cells, 88 as well as the presence of the receptor for erythropoietin. 89 In further support of murine VSEL pluripotency, these small cells also express bivalent domains at promoters for homeodomain-containing TFs, such as Sox21, Nkx2.2, Dlx1, Lbx1h, Hlxb9, Pax5, and HoxA3, which, as mentioned above, is one of the characteristics of PSCs. 48 Bivalent domains represent the state of chromatin structure in which transcriptionally opposite histone codes physically coexist in the same promoter of homeodomain-containing TFs. Although in undifferentiated PSCs bivalent domains prevent premature differentiation, during differentiation the transient repressive epigenetic marks in promoters of homeodomain-containing TFs become monovalent to activate or repress the expression of the appropriate TFs. The presence of transcriptionally active histone codes, such as trimethylated lysine 4 of histone 3, physically coexisting with repressive histone codes, like trimethylated lysine 27 of histone 3, within bivalent domains was confirmed by using the carrier-chromatin immunoprecipitation assay. 48 The phenomenon of X chromosome inactivation in female PSCs (eg, ESCs isolated from the female blastocyst ICM) is the epigenetic process for transcriptional silencing of 1 of the 2 X chromosomes in female cells to compensate for gene dosage. 119 It is well known that female-derived PSCs reactivate the X chromosome that is inactivated after fertilization, and, as a result, female PSCs display 2 equivalently activated X chromosomes. 120 Reactivation of the silenced X chromosome in female PSCs is one of the important features of pluripotency, and our results also indicate that VSELs purified from female mice partially activate an X chromosome, which indicates that murine VSELs, like ESCs, undergo the process of X chromosome reactivation.
In Vivo Differentiation of VSELs Reveals Their Pluripotent or Multipotent Character
It has been demonstrated in several elegant studies that purified VSELs differentiate into cells from different germ layers. Some of these exciting reports will be briefly discussed below. These reports demonstrate the pluripotent or multipotent character of these cells; however, to achieve robust differentiation and tissue contribution in vivo, a greater number of injected cells would be needed. Thus, our recent exciting results showing that VSELs can be expanded ex vivo will provide more of these cells for in vivo testing. Our group has demonstrated that BM-, mPB-or UCBderived VSELs could be specified into HSCs. 55, 56 Below, we will discuss data from other groups that demonstrated specification of VSELs into other types of adult cells.
VSELs at the Top of the Mesenchymal Lineage Hierarchy
In a very elegant study, Taichman et al 58 reported that VSELs isolated from GFP + (green fluorescent protein) mice formed bone-like structures when implanted into SCID (severe combined immunodeficiency) mice. To further confirm that this effect depends on VSELs that exhibit true MSC activity (bone formation), stromal cells were harvested from Col2.3∆TK mice and implanted into SCID mice to generate thymidine kinase-sensitive ossicles. At 1.5 months after implantation, these ossicles were injected with 2000 GFP + VSELs. At harvest, colocalization of GFP-expressing cells with antibodies to the osteoblast-specific marker Runx-2, the endothelial marker CD31, and the adipocyte marker PPARγ (peroxisome proliferator-activated receptor gamma) was observed. Based on the ability of uncultured VSELs to (1) differentiate in vivo into multiple mesenchymal lineages and (2) generate osseous tissues at low density, Taichman et al 58 proposed that VSELs fulfill many of the required characteristics of precursors for MSCs. Recently, a similar bone-forming potential of human VSELs has been demonstrated in vivo in an immunodeficient mouse model.
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VSELs as a Source of Endothelial Progenitors
In another elegant paper, Guerin et al 59 demonstrated that human VSELs are mobilized into PB in patients with critical limb ischemia, and in in vitro and in vivo assays human VSELs were able to differentiate into endothelial cells. Accordingly, VSEL-derived cells in vitro, like EPCs, released low levels of VEGF-A (vascular endothelial growth factor A) and a similar repertoire of inflammatory cytokines. More importantly, in an in vivo immunodeficient mouse model, human VSELs triggered postischemic revascularization, and in neovessels from plug sections, human CD31 + cells were detected. The authors concluded that VSELs are a potential new source of cells that could be specified into endothelial lineages for therapeutic applications in humans. 59 In support of these exciting results, we observed a high expression level of the Flk2 transcript in highly purified VSELs. This demonstrated potential of VSELs to differentiate into the endothelial lineage suggests their possible overlap with hemangioblast-like cells identified in adult BM.
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VSELs as Potential Precursors of Cardiomyocytes
VSELs are also promising cells for cardiac regeneration. As reported by Zuba-Surma et al, 63, 64 BM-derived VSELs freshly isolated from GFP + mice and injected into the hearts of mice that had undergone ischemia/reperfusion injury improved global and regional left ventricular systolic function as assessed by echocardiography and attenuated myocyte hypertrophy in surviving tissue (histology and echocardiography) compared with vehicle-treated controls. What is most important, newly formed GFP + cardiomyocytes and capillaries in infarcted myocardium were observed in these animals. 63, 64 Nevertheless, because not many newly formed cardiomyocytes were observed, the major effect of injected VSELs was most likely because of paracrine actions of the transplanted VSELs.
In another interesting study, VSELs were successfully isolated from rat BM by the Yuzhen Tan group, which demonstrated that VSEL-derived embryoid-like bodies in soft agarose models supplemented with leukemia inhibitory factor and basic fibroblast growth factor can differentiate into cells from the 3 germ layers, giving rise to cardiomyocytes and endothelial cells. 107 In further support of this finding, transplantation of these cells derived from male rats reduced the scar area and significantly improved cardiac function in a female rat myocardium infarction model. Moreover, analyzing cells for the donor-derived Y chromosome, the authors convincingly demonstrated the presence of male VSEL-derived cardiomyocytes and endothelial cells. The authors concluded that cells from VSEL-derived embryoid-like bodies may contribute to cardiomyogenesis and angiogenesis in vivo.
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VSELs and Their Contribution to Epithelial Cells
As mentioned above, ELH SCs isolated from murine BM differentiated into several epithelial lineages after injection into mice. 62 Because these cells share several characteristics with VSELs, Krause et al 61 tested whether VSELs purified from BM overlap with ELH SCs and compared the level of BMderived epithelial cells after transplantation of (1) VSELs, (2) hematopoietic stem/progenitor cells, and (3) other nonhematopoietic cells. It turned out that VSELs clearly had the highest rate of epithelial cell formation in the lung. Furthermore, in these elegant studies using VSELs from donor mice expressing H2B-GFP under a type 2 pneumocyte-specific promoter, Krause et al demonstrated that this engraftment occurs by differentiation of VSELs into type 2 pneumocytes, excluded the phenomenon of fusion, and concluded that ELH SCs and Oct4 + VSELs in the adult BM exhibit broad differentiation potential. 61 
Hepatocyte Differentiation of VSELs
In another recent study, Chen et al 60 reported that VSELs differentiate into hepatic colonies in the presence of hepatocyte growth factor and, if transplanted into mice with CCl 4 -induced liver injury, they significantly reduced serum ALT (alanine transaminase) and AST (aspartate transaminase) levels. It was therefore concluded that VSELs play a role in the repair of liver injury.
VSELs and Their Role in Gametogenesis
Finally, the potential role of VSELs in postnatal gametogenesis has been addressed by independent groups led by Viran-Klunt 18,106 and Bhartiya. [65] [66] [67] These investigators identified a population of very small cells in human and animal gonads that mimic VSELs. As they proposed, these cells could be used as an alternative source of oocytes and sperm in patients with damaged gonads after high-dose chemotherapy. In support of this possibility, VSELs are localized in the ovary surface epithelium and in the basement membrane of seminiferous tubules in testis. In appropriate in vitro and in vivo experiments, these cells gave rise to oocyte-like structures. 121 Moreover, they were also able to establish spermatogenesis in testis after a high dose of chemotherapy, followed by injection of MSCs or Sertoli cells. 67 These exciting results open up new possibilities for reproductive medicine. 18, 106 In Vivo Pluripotency Criteria, or Why Do VSELs Not Contribute to Blastocyst Development and Not Grow Teratomas?
Understanding the Consequences of Epigenetic Modification of Parentally Imprinted Genes
Accumulating evidence has unequivocally demonstrated that murine VSELs exhibit several features of PSCs. However, they do not fulfill 2 "gold standard" in vivo criteria of pluripotency that are seen in the cases of ESCs and inducible PSCs (iPSCs); namely, they (1) do not complete blastocyst development and (2) do not form teratomas after transplantation into immunodeficient mice. These in vivo pluripotency criteria were proposed based on research with ESCs and iPSCs. However, they do not apply to PGCs, which, despite being SCs endowed with developmental totipotency, do not comply with this definition. To explain this difference in PGCs, it has been reported that they modify the methylation of certain crucial parentally imprinted genes, 122 and this prevents them from proliferation, complementation of the blastocyst, and teratoma formation and, at the DNA level, explains their quiescent state. Taking into consideration the similarities in gene expression between PGCs and VSELs, 47 we have proposed and subsequently demonstrated 123 that a similar phenomenon may occur in VSELs, and this could explain their quiescent state in postnatal tissues. However, there are some differences in these epigenetic changes between PGCs and VSELs because VSELs, like PGCs, erase imprinting at certain crucial paternally imprinted genes, but PGCs, in contrast to VSELs, erase the imprinting of several maternally imprinted genes as well.
Overall, parental genomic imprinting is an epigenetic program that ensures the parent-of-origin-specific monoallelic transcription of parentally imprinted genes, which play a crucial role in embryogenesis, fetal growth, the totipotential state of the zygote, and the pluripotency of early-development SCs. 124 The expression of parentally imprinted genes from paternal or maternal chromosomes is regulated by DNA methylation at differentially methylated regions, which are CpG-rich cis-elements within the gene locus. 124 Evidence indicates that VSELs freshly isolated from murine BM erase the paternally methylated imprints (eg, at Igf2-H19 and Rasgrf1 loci); however, at the same time, they hypermethylate the maternally methylated imprints (eg, at the locus encoding the Igf2 receptor [Igf2R] and at the Kcnq1-p57 KIP2 and Peg1 loci). As a result of these epigenetic changes in the methylation state of differentially methylated regions in paternally imprinted genes, VSELs highly express growth-repressive genes (H19, p57
KIP2
, and Igf2R) and at the same time downregulate growth-promoting genes (Igf2 and Rasgrf1). These epigenetic changes cause a growth-repressive state in VSELs and a quiescent state, mainly by attenuating proteins that are involved in insulin-like growth factors 1 and 2 (IGF-1 and IGF-2) and insulin signaling, 123, 125, 126 including those encoded by the Igf2-H19 and Rasgrf1 loci. These erased loci are methylated during development in the gonads in PGC-derived gametes after the first meiotic division by de novo DNA methyltransferases. This step is required for normal development of the embryo after fertilization. 127 Based on these findings, it became obvious to us that, by methylation of erased differentially methylated regions at paternally imprinted loci by DNA methyltransferases, we would be able to reverse in vitro VSEL cultures more efficiently from the quiescent state.
123,128
Epigenetic Regulators Stimulate Remethylation of Erased Loci in Paternally Imprinted Genes and Facilitate Ex Vivo VSEL Expansion
As mentioned above, we assumed that the critical step in reversing the quiescent state of VSELs would be remethylation of the erased loci in parentally imprinted genes. We found that treatment of VSELs by the histone deacetylase (HDAC) inhibitors valporic acid (VPA) or nicotinamide remethylated the differentially methylated regions of parentally imprinted genes that were erased in VSELs. As a result, we were able to force the proliferation of VSELs and expand them ex vivo by ≈10 3 fold in chemically defined media in cultures supplemented with VPA and a cocktail of 2 pituitary SexHs, follicle-stimulating factor and luteinizing hormone together with BMP-4, IGF-2, and kit ligand. As mentioned above, follicle-stimulating factor and luteinizing hormone had been effective in stimulation of murine VSELs in vivo. 88 VSELs in these culture conditions began to proliferate, and after 1 to 2 months of expansion we can distinguish in our in vitro cultures many small cells (Figure 2) . In our expansion, many of small cells still express Oct-4 and some large cells express certain markers of the germ lineage (eg, Blimp-1 and Stella) at the protein level. These observations can be explained by the fact that the follicle-stimulating factor and luteinizing hormone present in expansion cultures maintained the germline potential of VSELs.
This novel expansion system is somewhat supported by recent data on the expansion of HSCs from CD133 + or CD34 + cells purified from UCB using immunomagnetic beads. 129, 130 These cells were effectively expanded in the presence of the HDAC inhibitors VPA 129, 131 or nicotinamide. 132, 133 Because immunomagnetic beads isolate both large and small cells, we propose that efficient expansion of long-term repopulating HSCs (LT-HSCs) from paramagnetically purified CD133 + or CD34 + cells was the result of expansion of small CD133 + or CD34 + VSELs that contaminated the immunomagnetically purified cells.
Specifically, in the first article in which Hoffman's group used VPA for the expansion of CD133 + cells, the authors observed an increase in the number of Oct-4 + cells, and this remarkable effect on the expansion of the most primitive LT-HSCs was reversed after Oct-4 had been downregulated by shRNA during expansion. 129 Therefore, because Oct-4 + VSELs can be specified into LT-HSCs, 55, 56 we envision that this effect was most likely because of the increased hematopoietic expansion of small CD133 + VSELs. However, we have to keep in mind that, by using HDAC inhibitors, not only are paternally methylated imprints released from an inhibitory complex with HDAC [134] [135] [136] but also the addition of these inhibitors increases the acetylation of histones in several genes. However, consistent with the crucial involvement of HDAC inhibition on the normal expression of paternally imprinted genes, we observed a similar effect when one of the HDACs was downregulated in VSELs by using an shRNA strategy (manuscript in preparation).
We are aware that this is a first step, and our expansion system is still open for optimization using different lineagespecific growth factors and other DNA modifiers-particularly HDAC inhibitors that are more potent and specific than VPA. However, what is very important, by developing this ex vivo-expansion protocol, we have demonstrated that VSELs can be woken up from their dormant/quiescent state and expanded ex vivo in cell cultures that are free of thirdparty feeder-layer cells or vectors for overexpressing genes involved in cell pluripotency, as proposed by Yamanaka and coworkers. [137] [138] [139] Finally, our work on VSELs and imprinted genes has for the first time connected the role of caloric restriction, the beneficial effect of regular exercise, insulin, and IGF-1/2 signaling, and metformin to the number of VSELs playing a role in tissue and organ rejuvenation. In particular, Sirt1 is an important HDAC that regulates all of these biological processes, and its high expression in VSELs keeps them in a quiescent state. Overall, our results suggest that imprinted genes are involved in longevity as guardians of the insulin/insulin-like growth factor-signaling quiescent state of VSELs. In support of this notion, we demonstrated that BM-residing VSELs can be prematurely depleted by enhanced insulin, IGF-1, or IGF-2 signaling, as seen for example after prolonged administration of IGF-1 or, in the case of transgenic mice that overexpress growth hormone, a stimulator of the IGF-1 level in blood. 140, 141 It is worthwhile mentioning that, as reported by other groups, downregulation of Sirt1 in BM cells leads to premature depletion of HSCs. 142, 143 Taking into consideration the possibility that VSELs play the role of precursors for LTHSCs, these observations explain why HDAC inhibition in VSELs promotes their controlled specification into LT-HSCs. This phenomenon may play a role in VSEL specification into other types of TCSCs and explains at the molecular level the novel role of HDAC in extending longevity. In fact, Laron dwarf and Ames dwarf mice, which have an elevated number of VSELs in tissues, are long-living animals.
Conclusions
Regenerative medicine is still looking for a reliable source of PSCs that could be safely used in the clinic. One of potential promising candidates are iPSCs; however, with advent of high-throughput technologies including next-generation sequencing evidence accumulated showing genomic instability of these cells. 144 In addition, the presence of genetic variations in iPSCs has raised serious safety concerns, hampering the advancement of iPSC-based novel therapies and first clinical trials in humans have been stopped. That is why it is important to emphasize that the only SCs to date that have been successfully used in the clinic are those isolated from postnatal tissues. Moreover, several recent publications support the presence of pluripotent or multipotent VSELs in adult tissues. These small cells seem to be at the top of the SC hierarchy in adult tissues and most likely play a role in tissue and organ rejuvenation as a source of adult TCSCs. Their premature depletion in adult tissues is prevented by decreasing insulin, IGF-1, and IGF-2 signaling, caloric restriction, metformin supplementation, and regular physical activity. HDACs play a crucial role in preventing remethylation of erased paternally imprinted loci, and their inhibition reverses the quiescent state of these cells in adult tissues. By inhibiting HDAC activity with VPA, we were able to successfully expand human and murine VSELs ex vivo. This latest development opens up new and exciting possibilities for application of these intriguing cells in regenerative medicine and sheds new light on the mechanisms affecting aging. 
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